U

A2i Therapeutics

Novel Small-molecule Immuno-oncology Agents
Startup Seed Founded 2020 Health Tech & Life Sciences
Last Update Nov 22, 2021

A2i Therapeutics Financials

Undisclosed
Total funding
Undisclosed
Capital raised
Undisclosed
Last funding
Seed
Funding stage
2
Total rounds
2
Investors

Cumulative Funding Raised Over Time ($)

Nov 2020

Private Equity Funding

Seed Nov 2020
Undisclosed
RMGP Biopharma Investment Fund, FutuRx

Non-Equity Funding

GrantEvent Nov 2020
Undisclosed
Israel Innovation Authority